The winner will depend on Phase 3 data, tolerability, approval timing, label breadth, payer access, and real-world persistence
These treatments can help reduce appetite, control cravings, and make it easier to stay in a calorie deficit
Many OTC (over-the-counter) weight loss supplements make big claims (boost metabolism, burn fat, block carbs) without proof
[7] [8] Readers should check the current NICE Technology Appraisal for tirzepatide in weight management and the emc SmPC (medicines.org.uk) for the most up-to-date information on its licensed indications and eligibility criteria in the UK, as guidance may be updated
is supported by a Presidents PhD Scholarship from Imperial College London, and A.I.O
Around 20% of GLP-1 users report reduced alcohol consumption since starting the medication, 6 and FTI Consulting analysis estimates that adoption could cut cumulative U.S